Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 23, 2021
Persistent severe lymphopenia 5 years after dimethyl fumarate discontinuationNatalia Gonzalez Caldito, Shirley O'Leary, Olaf StuveCurrent Medical Research and Opinion|February 13, 2009
A review of disease-modifying therapies for MS: maximizing adherence and minimizing adverse eventsDavid W Brandes, Teri Callender, Ellen Lathi, et al.Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society|March 16, 2010
Best practices in multiple sclerosis: infusion reactions versus hypersensitivity associated with biologic therapiesMarie Namey, June Halper, Shirley O'leary, et al.The Neurologist|June 14, 2003
Disease-modifying therapy in multiple sclerosis: strategies for optimizing managementElliot Frohman, Ted Phillips, Kristen Kokel, et al.International Journal of MS Care|April 2, 2014
Nurses' perspective on approaches to limit flu-like symptoms during interferon therapy for multiple sclerosisMary L Filipi, Jill Beavin, Raquel T Brillante, et al.Journal of Neurology|February 26, 2016
Acute relapse after initiation of Siponimod in a patient with secondary progressive MSRehana Hussain, Shirley O'Leary, Fides M Pacheco, et al.Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society|November 3, 2023
Practical Clinical Guidelines for Natalizumab Treatment in Patients With Relapsing Multiple SclerosisShirley O'Leary, Helen T Brugger, Dale Wallentine, et al.Pageof 1